(Q46662710)

English

Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group B.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group B (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Gloria Broadwater

4

object named as

Gloria Broadwater

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

10

object named as

Hyman B Muss

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

11

object named as

Donald A Berry

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Daniel R. Budman

6

object named as

Daniel R Budman

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Lynn G Dressler

5

object named as

Lynn G Dressler

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Michael P DiGiovanna

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

David F Stern

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Susan Edgerton

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

I Craig Henderson

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Edison T Liu

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Daniel F Hayes

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Ann D Thor

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

0 references

publication date

7 April 2008

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

26

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

2364-2372

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New prognostic factors for breast cancer recurrence

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of topoisomerase II activity after ErbB2 activation is associated with a differential response to breast cancer chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy response of breast cancer depends on HER-2 status and anthracycline dose intensity in the neoadjuvant setting.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2/neu and topoisomerase IIalpha in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER2 and responsiveness of breast cancer to adjuvant chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation state-specific monoclonal antibody detects tyrosine phosphorylated p185neu/erbB-2 in a subset of human breast tumors overexpressing this receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Co-amplification of erbB2, topoisomerase II alpha and retinoic acid receptor alpha genes in breast cancer and allelic loss at topoisomerase I on chromosome 20

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional assay for HER-2/neu demonstrates active signalling in a minority of HER-2/neu-overexpressing invasive human breast tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18390970

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2007.13.6580

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18390970%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46662710&oldid=1857453734"